Literature DB >> 8371147

The cardioprotective, vasorelaxant and electrophysiological profile of the large conductance calcium-activated potassium channel opener NS-004.

C A Sargent1, G J Grover, M J Antonaccio, J R McCullough.   

Abstract

A series of compounds have been reported which open the large conductance calcium activated potassium channel (maxi-K). By utilizing the most potent compound, NS-004 [1-(5-chloro-2-hydroxyphenyl)-5-trifluromethyl-1,3-dihydro-2-be nzimidazol-2- one], we studied the role of maxi-K channels in ischemic myocardium. Isolated rat hearts were pretreated with vehicle or NS-004 (6-36 microM). NS-004 caused a concentration-dependent reduction in left ventricular developed pressure and an increase in coronary flow. In global ischemia (25 min), a concentration-dependent increase in time to contracture was found in NS-004 (6-20 microM)-treated hearts (EC25 = 8.6 microM). Neither iberiotoxin (50 nM), a maxi-K blocker, nor glyburide (1 microM), an adenosine triphosphate-sensitive potassium channel blocker, reversed the preischemic or ischemic effects of 20 microM NS-004. NS-004 relaxed phenylephrine- and KCl- contracted rat aortic smooth muscle (IC50 = 9.2 microM). This relaxation was unaffected by 50 and 200 nM iberiotoxin. Whole cell potassium currents in ventricular myocytes demonstrated no significant increases in outward potassium current after treatment with NS-004 (1-20 microM). A small, but significant, increase in outward potassium current was observed with 50 microM NS-004. When peak inward L-type calcium currents were measured in ventricular myocytes, a concentration-dependent inhibition was observed in the presence of NS-004 (1-50 microM). Iberiotoxin (50 nM) did not alter the inhibition of inward calcium current observed in the presence of NS-004.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8371147

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  BK channel activation by NS-1619 is partially mediated by intracellular Ca2+ release in smooth muscle cells of porcine coronary artery.

Authors:  H Yamamura; Y Ohi; K Muraki; M Watanabe; Y Imaizumi
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

2.  Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels.

Authors:  Vincenzo Calderone; Silvio Chericoni; Cinzia Martinelli; Lara Testai; Antonio Nardi; Ivano Morelli; Maria Cristina Breschi; Enrica Martinotti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-17       Impact factor: 3.000

3.  Functional contribution of the endothelial component to the vasorelaxing effect of resveratrol and NS 1619, activators of the large-conductance calcium-activated potassium channels.

Authors:  Vincenzo Calderone; Alma Martelli; Lara Testai; Enrica Martinotti; Maria C Breschi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-04       Impact factor: 3.000

Review 4.  Thiazide-induced hyperglycaemia: a role for calcium-activated potassium channels?

Authors:  P Pickkers; M Schachter; A D Hughes; M D Feher; P S Sever
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

Review 5.  High-conductance calcium-activated potassium channels; structure, pharmacology, and function.

Authors:  G J Kaczorowski; H G Knaus; R J Leonard; O B McManus; M L Garcia
Journal:  J Bioenerg Biomembr       Date:  1996-06       Impact factor: 2.945

6.  In vivo evidence for K(Ca) channel opening properties of acetazolamide in the human vasculature.

Authors:  P Pickkers; A D Hughes; F G Russel; T Thien; P Smits
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 7.  The Slo(w) path to identifying the mitochondrial channels responsible for ischemic protection.

Authors:  Charles Owen Smith; Keith Nehrke; Paul S Brookes
Journal:  Biochem J       Date:  2017-06-09       Impact factor: 3.857

8.  Effects of the BKCa channel activator, NS1619, on rat cerebral artery smooth muscle.

Authors:  M Holland; P D Langton; N B Standen; J P Boyle
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  Ion channel modulation by NS 1619, the putative BKCa channel opener, in vascular smooth muscle.

Authors:  G Edwards; A Niederste-Hollenberg; J Schneider; T Noack; A H Weston
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

10.  Effects of cromakalim or pinacidil on pacing- and ischemia-induced ventricular fibrillation in the anesthetized pig.

Authors:  A J D'Alonzo; T A Hess; R B Darbenzio; J C Sewter; M L Conder; J R McCullough
Journal:  Basic Res Cardiol       Date:  1994 Mar-Apr       Impact factor: 17.165

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.